Greenies

A former player opens up about PEDs

52 Comments

David Laurila of FanGraphs has a fascinating interview with a former pitcher — now retired — about his PED use. It’s not clear whether this guy was a major leaguer, but his comments about PED use — extremely detailed comments about what they did for him and how they made him feel — refer to his time in the minors.

He took steroids and amphetamines of various kinds. It’s worth noting that he felt significant effects from all of them, though the psychological effects come off stronger with the steroids and the physical effects come off stronger with the greenies. Oh, and the Adderall:

“The next step would be to get an Adderall or another ADD medication. Legal amphetamine prescriptions are how I circumvented drug testing. Now I had a “medical issue” which required Adderall. When I stood on the mound while on Adderall, everything faded away except for the catcher’s mitt. No crowd noise, no distractions. It was almost like being in the Matrix. Although you were sped up, everything slowed down.

A reminder that a far greater percentage of players in Major League Baseball have therapeutic use exemptions for ADD medicine than the population at large. People tend not to be critical of that, but I suspect the quotes around “medical issue” here apply to a great many of them.

Beyond that, a really good insight into PED use by players. I wish, rather than making a show of naming names and creating the perp-walk that was the Mitchell Report, baseball had actually tried to investigate PED use like this by talking to players anonymously and trying to explain and understand the reasons and habits behind PED-cheating as a means of getting at the problem and, for a time anyway, declaring the problem as one in the past.

Magic Johnson to take over the Lakers, but will still be part of Dodgers ownership

CHICAGO, IL - OCTOBER 15:  Earvin 'Magic' Johnson attends game one of the National League Championship Series between the Chicago Cubs and the Los Angeles Dodgers at Wrigley Field on October 15, 2016 in Chicago, Illinois.  (Photo by Jonathan Daniel/Getty Images)
Getty Images
Leave a comment

This is more significant for basketball fans than baseball fans, but Magic Johnson is taking over basketball operations for the Los Angeles Lakers. Dan Feldman over at PBT has the full story on that.

For our purposes, you probably know that Johnson is part of the Dodgers ownership group. Anthony McCullough of the L.A. Times got comment from the Dodgers, saying that despite his new full-time job, his status with the Dodgers will be unchanged:

Maybe I’m alone in this, but I’m not entirely certain what Magic does with the Lakers, so the first clause in Kasten’s comment may be doing most of the heavy lifting here.

Matt Wieters is close to signing with the Washington Nationals

NEW YORK, NY - OCTOBER 02: Matt Wieters #32 of the Baltimore Orioles connects on a two-run home run in the fourth inning against the New York Yankees at Yankee Stadium on October 2, 2016 in the Bronx borough of New York City.  (Photo by Mike Stobe/Getty Images)
Getty Images
4 Comments

Jon Heyman reports that the Nationals are closing in on a deal with catcher Matt Wieters. Joel Sherman of the New York Post reports that it’s a two-year deal. UPDATE: Ken Rosenthal reports that the deal is for two years, at $21 million. There is an opt-out for him after year one. He will get $10 million in 2017 and, if he returns in 2018, he’ll get $11 million.

Wieters was not expected to go this long without signing, but his market, which many thought would be robust, never materialized. The Nats had been rumored to be interested for months, but they were apparently waiting to swoop in late and get what one presumes will be a bargain.

Wieters, 30, finished last season hitting .243/.302/.409 with 17 home runs and 66 RBI in 464 plate appearances. The Nationals currently have Derek Norris and Jose Lobaton, so who falls where in the catcher fight in Washington is unclear, but one presumes that Wieters getting a two-year deal puts him at the top of the depth chart.